BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Zhang L, Wang H, Chen L, Sui G. Diagnostic performance of contrast-enhanced ultrasound and magnetic resonance imaging for detecting colorectal liver metastases: A systematic review and meta-analysis. Digestive and Liver Disease 2019;51:1241-8. [DOI: 10.1016/j.dld.2019.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Tsili AC, Alexiou G, Naka C, Argyropoulou MI. Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis. Acta Radiol 2021;62:302-12. [PMID: 32506935 DOI: 10.1177/0284185120925481] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
2 Jian M, Ren L, He G, Lin Q, Tang W, Chen Y, Chen J, Liu T, Ji M, Wei Y, Chang W, Xu J. A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases. J Transl Med 2020;18:234. [PMID: 32532289 DOI: 10.1186/s12967-020-02407-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Deng S, Jiang Q, Wang Y, Lu X, Zhang Y. Relationship between quantitative contrast-enhanced ultrasonography parameters and angiogenesis in primary small hepatocellular carcinoma: A retrospective study. Medicine (Baltimore) 2021;100:e26489. [PMID: 34232180 DOI: 10.1097/MD.0000000000026489] [Reference Citation Analysis]
4 Ren Y, Chen L, Huang S, Zhou C, Liu J, Shi Q, Yang C, Chen R, Zheng C, Han P, Xiong B. Transarterial chemoembolization of unresectable systemic chemotherapy refractory liver metastases: a retrospective single-center analysis. Abdom Radiol (NY) 2020;45:2862-70. [PMID: 32468211 DOI: 10.1007/s00261-020-02584-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]